Common use of FORM OF PRICING SUPPLEMENT Clause in Contracts

FORM OF PRICING SUPPLEMENT. The Pricing Supplement in respect of each Series of Notes will be substantially in the following form, duly supplemented (if necessary), amended (if necessary) and completed to reflect the particular terms of the relevant Notes and their issue. Pricing Supplement dated [●] [Bank of China Limited/[specify Branch Issuer]]/[specify Subsidiary Issuer] Issue of [Aggregate Nominal Amount of Series] [Title of Notes] under the U.S.$40,000,000,000 Medium Term Note Programme [guaranteed by Bank of China Limited [, [specify] Branch]] “MiFID II product governance/target market – [appropriate target market legend to be included]” [PRIIPs Regulation/[Prospectus Regulation/] PROHIBITION OF SALES TO EEA and UK RETAIL INVESTORS – The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area (“EEA”) or in the United Kingdom (the “UK”). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, “MiFID II”); (ii) a customer within the meaning of Directive (EU) 2016/97 (the “Insurance Distribution Directive”), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129 (the “Prospectus Regulation”). Consequently no key information document required by Regulation (EU) No 1286/2014 (as amended, the “PRIIPs Regulation”) for offering or selling the Notes or otherwise making them available to retail investors in the EEA or in the UK has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA or in the UK may be unlawful under the PRIIPs Regulation.] [This document is for distribution to professional investors (as defined in Chapter 37 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”) and in the Securities and Futures Ordinance (Cap. 571 of Hong Kong) (together, “Professional Investors”) only. Investors should not purchase the Notes in the primary or secondary markets unless they are Professional Investors and understand the risks involved. The Notes are only suitable for Professional Investors. The Hong Kong Stock Exchange has not reviewed the contents of this document, other than to ensure that the prescribed form disclaimer and responsibility statements, and a statement limiting distribution of this document to Professional Investors only have been reproduced in this document. Listing of the Programme and the Notes on Hong Kong Stock Exchange is not to be taken as an indication of the commercial merits or credit quality of the Programme, the Notes, the Issuer[, the Guarantor] or quality of disclosure in this document. Hong Kong Exchanges and Clearing Limited and the Hong Kong Stock Exchange take no responsibility for the contents of this document, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this document. This document includes particulars given in compliance with the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited for the purpose of giving information with regard to the Issuer [and the Guarantor]. The Issuer [and the Guarantor each] accepts full responsibility for the accuracy of the information contained in this document and confirms, having made all reasonable enquiries, that to the best of its knowledge and belief there are no other facts the omission of which would make any statement herein misleading.] [Singapore Securities and Futures Act Product Classification – Solely for the purposes of its obligations pursuant to sections 309B(1)(a) and 309B(1)(c) of the Securities and Futures Act (Chapter 289 of Singapore) (the “SFA”), the Issuer has determined, and hereby notifies all relevant persons (as defined in Section 309A of the SFA) that the Notes are “prescribed capital markets products” (as defined in the Securities and Futures (Capital Markets Products) Regulations 2018) and “Excluded Investment Products” (as defined in MAS Notice SFA 04-N12: Notice on the Sale of Investment Products and MAS Notice FAA-N16: Notice on Recommendations on Investment Products).] The document constitutes the Pricing Supplement relating to the issue of Notes described herein. Terms used herein shall be deemed to be defined as such for the purposes of the Conditions (the “Conditions”) set forth in the Offering Circular dated 28 April 2020. This Pricing Supplement contains the final terms of the Notes and must be read in conjunction with such Offering Circular [and the supplemental Offering Circular dated [date]]. [The following alternative language applies if the first tranche of an issue which is being increased was issued under an Offering Circular with an earlier date. Terms used herein shall be deemed to be defined as such for the purposes of the Conditions (the “Conditions”) set forth in the Offering Circular dated 28 April 2020. This Pricing Supplement contains the final terms of the Notes and must be read in conjunction with the Offering Circular dated 28 April 2020 [and the supplemental Offering Circular dated [●]], save in respect of the Conditions which are extracted from the Offering Circular dated 28 April 2020 and are attached hereto.] [Include whichever of the following apply or specify as “Not Applicable” (N/A). Note that the numbering should remain as set out below, even if “Not Applicable” is indicated for individual paragraphs or subparagraphs. Italics denote guidance for completing the Pricing Supplement.]

FORM OF PRICING SUPPLEMENT. The form of Pricing Supplement that will be issued in respect of each Series Tranche, subject only to the deletion of Notes will be substantially in the following formnon-applicable provisions, duly supplemented (if necessary), amended (if necessary) and completed to reflect the particular terms of the relevant Notes and their issue. Pricing Supplement dated [●] [Bank of China Limited/[specify Branch Issuer]]/[specify Subsidiary Issuer] Issue of [Aggregate Nominal Amount of Series] [Title of Notes] under the U.S.$40,000,000,000 Medium Term Note Programme [guaranteed by Bank of China Limited [, [specify] Branch]] “MiFID II product governance/target market – [appropriate target market legend to be included]” is set out below: [PRIIPs Regulation/[Prospectus Regulation/] REGULATION – PROHIBITION OF SALES TO EEA and UK RETAIL INVESTORS – The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area (“EEA”) or in the United Kingdom (the “UK”). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, “MiFID II”); (ii) a customer within the meaning of Directive (EU) 2016/97 (as amended, the “Insurance Distribution Directive”), where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II[; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129 (as amended, the “Prospectus Regulation”)]. Consequently no key information document required by Regulation (EU) No 1286/2014 (as amended, amended the “PRIIPs Regulation”) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation. UK PRIIPs REGULATION – PROHIBITION OF SALES TO UK RETAIL INVESTORS – The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor [United Kingdom (“UK”)]/[UK]. For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (“EUWA”); (ii) a customer within the meaning of the provisions of the FSMA and any rules or regulations made under the Financial Services and Markets Act 2000 (“FSMA”) to implement Directive (EU) 2016/97, where that customer would not qualify as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA[.]/[; or] [(iii) not a qualified investor as defined in Article 2 of Regulation (EU) 2017/1129 as it forms part of domestic law by virtue of the EUWA]. Consequently no key information document required by Regulation (EU) No 1286/2014 as it forms part of domestic law by virtue of the EUWA (the “UK PRIIPs Regulation”) for offering or selling the Notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA or in the UK may be unlawful under the UK PRIIPs Regulation.] [This document is for distribution to professional MiFID II product governance/Professional investors (as defined in Chapter 37 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”) and in the Securities and Futures Ordinance (Cap. 571 of Hong Kong) (together, “Professional Investors”) only. Investors should not purchase the Notes in the primary or secondary markets unless they are Professional Investors and understand the risks involved. The Notes are ECPs only suitable for Professional Investors. The Hong Kong Stock Exchange has not reviewed the contents of this document, other than to ensure that the prescribed form disclaimer and responsibility statements, and a statement limiting distribution of this document to Professional Investors only have been reproduced in this document. Listing of the Programme and the Notes on Hong Kong Stock Exchange is not to be taken as an indication of the commercial merits or credit quality of the Programme, the Notes, the Issuer[, the Guarantor] or quality of disclosure in this document. Hong Kong Exchanges and Clearing Limited and the Hong Kong Stock Exchange take no responsibility for the contents of this document, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this document. This document includes particulars given in compliance with the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited for the purpose of giving information with regard to the Issuer [and the Guarantor]. The Issuer [and the Guarantor each] accepts full responsibility for the accuracy of the information contained in this document and confirms, having made all reasonable enquiries, that to the best of its knowledge and belief there are no other facts the omission of which would make any statement herein misleading.] [Singapore Securities and Futures Act Product Classification target market – Solely for the purposes of [the/each] manufacturer’s product approval process, the target market assessment in respect of the Notes has led to the conclusion that: (i) the target market for the Notes is eligible counterparties and professional clients only, each as defined in [Directive 2014/65/EU (as amended, “MiFID II”)]/[MiFID II]; and (ii) all channels for distribution of the Notes to eligible counterparties and professional clients are appropriate. [Consider any negative target market] Any person subsequently offering, selling or recommending the Notes (a “distributor”) should take into consideration the manufacturer[‘s/s’] target market assessment; however, a distributor subject to MiFID II is responsible for undertaking its obligations pursuant to sections 309B(1)(aown target market assessment in respect of the Notes (by either adopting or refining the manufacturer[‘s/s’] target market assessment) and 309B(1)(cdetermining appropriate distribution channels. UK MiFIR product governance/Professional investors and ECPs only target market – Solely for the purposes of [the/each] manufacturer’s product approval process, the target market assessment in respect of the Notes has led to the conclusion that: (i) the target market for the Notes is only eligible counterparties, as defined in the FCA Handbook Conduct of Business Sourcebook (“COBS”), and professional clients, as defined in Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (“UK MiFIR”); and (ii) all channels for distribution of the Notes to eligible counterparties and professional clients are appropriate. [Consider any negative target market.] Any person subsequently offering, selling or recommending the Notes (a “distributor”) should take into consideration the manufacturer[’s/s’] target market assessment; however, a distributor subject to the FCA Handbook Product Intervention and Product Governance Sourcebook (the “UK MiFIR Product Governance Rules”) is responsible for undertaking its own target market assessment in respect of the Notes (by either adopting or refining the manufacturer[’s/s’] target market assessment) and determining appropriate distribution channels.] [Singapore SFA Product Classification: In connection with Section 309B of the Securities and Futures Act (Chapter 289 289) of Singapore) , as modified or amended from time to time (the “SFA”) and the Securities and Futures (Capital Markets Products) Regulations 2018 of Singapore (the “CMP Regulations 2018”), the Issuer has determined, and hereby notifies all relevant persons (as defined in Section 309A 309A(1) of the SFA) ), that the Notes are “[prescribed capital markets products]/[capital markets products other than prescribed capital markets products” ] (as defined in the Securities and Futures (Capital Markets Products) CMP Regulations 2018) and “Excluded [are] [Excluded]/[Specified] Investment Products” Products (as defined in MAS Notice SFA 04-N12: Notice on the Sale of Investment Products and MAS Notice FAA-N16: Notice on Recommendations on Investment Products)Products).]1 Pricing Supplement dated [●] [CHINA ZHESHANG BANK CO., LTD. 浙商銀行股份有限公司/CHINA ZHESHANG BANK CO., LTD. (HONG KONG BRANCH)]2 Issue of [Aggregate Nominal Amount of Tranche] The [Title of Notes] under the U.S.$.2,000,000,000 Medium Term Note Programme This document constitutes the Pricing Supplement relating to for the issue of Notes described herein. Terms used herein shall be deemed to be defined as such for the purposes of the Terms and Conditions (the “Conditions”) set forth in the Offering Circular dated 28 April 2020Circular. This Pricing Supplement contains the final terms of the Notes and must be read in conjunction with such the Offering Circular dated [●] [and the supplemental Offering Circular dated [date●]]] ([together,] the “Offering Circular”). [This Pricing Supplement, together with the information set out in Schedule [●] to this Pricing Supplement, supplements the Offering Circular and supersedes the information in the Offering Circular to the extent inconsistent with the information included therein.] Full information on the Issuer and the offer of the Notes is only available on the basis of the combination of this Pricing Supplement and the Offering Circular. [The following alternative language applies if the first tranche of an issue which is being increased was issued under an Offering Circular with an earlier date. : Terms used herein shall be deemed to be defined as such for the purposes of the Terms and Conditions (the “Conditions”) set forth in the Offering Circular dated 28 April 2020on or about [●]. This Pricing Supplement contains the final terms of the Notes and must be read in conjunction with the Offering Circular dated 28 April 2020 on or about [●] [and the supplemental Offering Circular dated [●]], save in respect of the Conditions which are extracted from the Offering Circular dated 28 April 2020 on or about [●] and are attached hereto.] [Include whichever The following language applies where the relevant Series of Notes will be listed on the Hong Kong Stock Exchange: This document is for distribution to professional investors (as defined in Chapter 37 of the following apply or specify as Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited) (“Not Applicable” (N/A). Note that the numbering should remain as set out below, even if “Not Applicable” is indicated for individual paragraphs or subparagraphs. Italics denote guidance for completing the Pricing SupplementProfessional Investors”) only.]

FORM OF PRICING SUPPLEMENT. The Pricing Supplement in respect of each Series Tranche of Notes that are Exempt Notes will be substantially in the following form, duly supplemented (if necessary), amended (if necessary) form and will be completed to reflect the particular terms of the relevant Exempt Notes and their issue. Text in this section appearing in italics does not form part of the form of the Pricing Supplement dated [●] [Bank but denotes directions for completing the Pricing Supplement. The applicable Pricing Supplement in relation to any Tranche of China Limited/[specify Branch Issuer]]/[specify Subsidiary Issuer] Issue Notes that are Exempt Notes may specify other terms and conditions which will, to the extent so specified or to the extent inconsistent with the Conditions, complete and/or amend and/or replace such Conditions for the purpose of [Aggregate Nominal Amount of Series] [Title of such Exempt Notes] under the U.S.$40,000,000,000 Medium Term Note Programme [guaranteed by Bank of China Limited [, [specify] Branch]] “MiFID II product governance/target market – [appropriate target market legend to be included]” [PRIIPs Regulation/[Prospectus Regulation/] . PROHIBITION OF SALES TO EEA and UK RETAIL INVESTORS – The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area (“EEA”) or in the United Kingdom (the “UK”). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, “MiFID II”); (ii) a customer within the meaning of Directive (EU) 2016/97 (as amended, the “Insurance Distribution Directive”), ) where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in the Prospectus Regulation (EU) 2017/1129 (the “Prospectus Regulation”as defined below). Consequently Consequently, no key information document informationdocument required by Regulation (EU) No 1286/2014 (as amended, the “PRIIPs Regulation”) for offering or selling the Notes or otherwise making them available to retail investors in the EEA or in the UK has been prepared and therefore andtherefore offering or selling the Notes or otherwise making them available to any retail investor in the EEA may be unlawful under the PRIIPs Regulation. PROHIBITION OF SALES TO UK RETAIL INVESTORS – The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom(“UK”). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended, the “EUWA”); (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the “ FS MA” ) and any rules or regulations made under the FSMA to implement the Insurance Distribution Directive, where that customer would not qualify as a professional client, as definedin point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of UK domestic law by virtue of the EUWA (“UK MiFIR”); or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129 as it forms part of UK domestic law by virtue of the EUWA. Consequently, no key information document required by the PRIIPs Regulation as it forms part of UK domestic law by virtue of the EUWA (the “UK PRIIPs Regulation”) for offering or selling the Notes or otherwise making themavailable to retail investors in the UK has been prepared and therefore offering or selling the Notes or otherwise making themavailable to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.] [This document is for distribution to professional . MiFID II Product Governance / Professional investors (as defined in Chapter 37 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “Hong Kong Stock Exchange”) and in the Securities and Futures Ordinance (Cap. 571 of Hong Kong) (together, “Professional Investors”) only. Investors should not purchase the Notes in the primary or secondary markets unless they are Professional Investors and understand the risks involved. The Notes are ECPs only suitable for Professional Investors. The Hong Kong Stock Exchange has not reviewed the contents of this document, other than to ensure that the prescribed form disclaimer and responsibility statements, and a statement limiting distribution of this document to Professional Investors only have been reproduced in this document. Listing of the Programme and the Notes on Hong Kong Stock Exchange is not to be taken as an indication of the commercial merits or credit quality of the Programme, the Notes, the Issuer[, the Guarantor] or quality of disclosure in this document. Hong Kong Exchanges and Clearing Limited and the Hong Kong Stock Exchange take no responsibility for the contents of this document, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this document. This document includes particulars given in compliance with the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited for the purpose of giving information with regard to the Issuer [and the Guarantor]. The Issuer [and the Guarantor each] accepts full responsibility for the accuracy of the information contained in this document and confirms, having made all reasonable enquiries, that to the best of its knowledge and belief there are no other facts the omission of which would make any statement herein misleading.] [Singapore Securities and Futures Act Product Classification target market – Solely for the purposes of its obligations pursuant to sections 309B(1)(a) and 309B(1)(c) each manufacturer’s product approval process, the target market assessment in respect of the Securities Notes has led to the conclusion that: (i) the target market for the Notes is eligible counterparties and Futures Act (Chapter 289 of Singapore) (the “SFA”)professional clients only, the Issuer has determined, and hereby notifies all relevant persons (each as defined in Section 309A MiFID II and (ii) all channels for distribution of the SFA) that Notes to eligible counterparties and professional clients are appropriate. Any person subsequently offering, selling or recommending the Notes are (a “prescribed capital markets products” distributor”) should take into consideration the manufacturers’ target market assessment; however, a distributor subject to MiFID II is responsible for undertaking it s own target market assessment in respect of the Notes (by either adoptingor refining the manufacturers’ target market assessment) and determining appropriate distribution channels. UK MiFIR product governance / Professional investors and ECPs only target market – Solely for the purposes of each manufacturer’s product approval process, the target market assessment in respect of the Notes has led to the conclusion that: (i) the target market for the Notes is only eligible counterparties, as defined in the Securities FCA Handbook Conduct of Business Sourcebook (“COBS”), and Futures (Capital Markets Products) Regulations 2018) and “Excluded Investment Products” (professional clients, as defined in MAS Notice SFA 04-N12: Notice on UK MiFIR; and (ii) all channels for distribution of the Sale Notes to eligible counterparties and professional clients are appropriate. A distributor should take into consideration the manufacturers’ target market assessment; however, a distributor subject to the FCA Handbook Product Intervention and Product Governance Sourcebook (the “ UK MiFIR Product Governance Rules”) is responsible for undertaking its own target market assessment in respect of Investment Products the Notes (by either adopting or refining the manufacturers’ target market assessment) and MAS Notice FAA-N16: Notice on Recommendations on Investment Products).] The document constitutes the determining appropriate distribution channels. NO PROSPECTUS IS REQUIRED IN ACCORDANCE WITH REGULATION (EU) 2017/1129 (AS AMENDED) (THE “PROSPECTUS REGULATION”) FOR THE ISSUE OF NOTES DESCRIBED BELOW. Pricing Supplement relating dated [●] XXXXXXXXX GROUP LLC Issue of [Aggregate Nominal Amount of Tranche][Title of Notes] under the U.S.$2,500,000,000 Euro Medium Term Note Programme Part A Contractual Terms Any person making or intending to make an offer of the issue Notes may only do so in circumstances in which no obligation arises for the Issuer or any Dealer to publish a prospectus pursuant to Article 3 of Notes described hereinthe Prospectus Regulation or to supplement a prospectus pursuant to Article 23 of the Prospectus Regulation, in each case, in relation to such offer. Terms used herein shall be deemed to be defined as such for the purposes of the Conditions terms and conditions (the “Conditions”) set forth in the Offering Circular Base Prospectus dated 28 April 202014 July 2021 [and the supplement( s) to it dated [●]] which [together] constitute[s] a base prospectus (the “Base Prospectus”). This doc ument constitutes the Pricing Supplement contains the final terms of for the Notes described herein and must be read in conjunction with such Offering Circular [the Base Prospectus. Full information on the Issuer and the supplemental Offering Circular dated [date]]offer of the Notes is only available on the basis of the combination of this Pricing Supplement and the Base Prospectus. The Base Prospectus has been published on the website of Euronext Dublin (xxxxx://xxxx.xxxxxxxx.xxx/). [The following alternative language applies if the first tranche of an issue which is being increased was issued under an Offering Circular a Base Prospectus with an earlier date. date and the relevant terms and conditions f rom that base prospectus with an earlier date were incorporated by reference in this Base Prospectus.] Terms used herein shall be deemed to be defined as such for the purposes of the Conditions terms and conditions of the Notes (the “Conditions”) set forth in the Offering Circular Base Prospectus dated 28 [[3 May 2012]/[3 May 2013]/[9 May 2014]/[30 April 2015]/[29 April 2016]/[28 April 2017]/[18 June 2018]/[5 July 2019] /[13 July 2020]] (the “Original Base Prospectus”), which are incorporated in the Base Prospec tus dated 14 July 2021 [and the supplement(s) to it dated [●]] which [together] constitute[s] a base prospectus (the “Base Prospectus”). This document constitutes the Pricing Supplement contains the final terms of for the Notes described herein and must be read in conjunction with the Offering Circular dated 28 April 2020 [and the supplemental Offering Circular dated [●]], Base Prospectus save in respect of the Conditions which are extracted from the Offering Circular dated 28 April 2020 Original Base Prospectus and are attached hereto.] incorporated by reference in the Base Prospectus. Full information on the Issuer and the offer of the Notes is only available on the basis of the combination of this Pricing Supplement and the Base Prospectus. The Base Prospectus has been published on the website of Euronext Dublin (xxxxx://xxxx.xxxxxxxx.xxx/). [Include whichever of the following apply or specify as “Not Applicable” (N/A). Note that the numbering should remain as set out below, even if “Not Applicable” is indicated for individual paragraphs or subparagraphs(in which case the sub-paragraphs of the paragraphs which are not applicable can be deleted). Italics denote guidance for completing the Pricing Supplement.]